Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

B of A Securities Maintains Underperform on Sutro Biopharma, Lowers Price Target to $0.8

Author: Benzinga Newsdesk | May 19, 2025 01:58pm

B of A Securities analyst Tazeen Ahmad maintains Sutro Biopharma (NASDAQ:STRO) with a Underperform and lowers the price target from $1 to $0.8.

Posted In: STRO